Recent

% | $
Quotes you view appear here for quick access.

Pacifichealth Laboratories Inc. Message Board

  • pontb2000 pontb2000 Dec 24, 2009 9:38 AM Flag

    Earnings...

    Anyone know when the call is scheduled for Q4 earnings?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think that the hiring of a national sales force may reduce bottom line earnings in the near term, but supports a growth plan.....

      Company is undervalued, but may stay there until Marketing Plan gains traction.

      (Excludes G&A Expense, which is consistently in the 3 - 4M range)

      (Some Decimal Rounding)

      Fair Value for the Company: 5.16M

      Factored to Shares / EV Factor: .34

      Due to the implementation of the sales and marketing plan and product awareness: I am looking for a price target of:

      .0715_136, with a Price to EV: .21

      Theoretical Multi Year upside potential: 378.82%

      Some Notes:

      PacificHealth Laboratories (hereinafter referred to as the “Company”, “us”, or “we”) is a leading nutrition company.
      We focus on the development, marketing and selling of patented premium nutrition tools that enable our consumers to enhance their health and improve their performance.

      Our principal area of focus is exercise performance and recovery, including optimal weight management.
      Our products can be marketed without prior Food and Drug Administration (“FDA”) approval under current regulatory guidelines.

      We are evolving into a more consumer oriented, brand driven company that derives value from its own brands based on our science-based nutrition technology.

      We have previously been a pioneer in the development of patented nutritional products that activate biochemical pathways to enhance muscle endurance and additionally the specific peptides involved in appetite regulation.

      Today, we employ multiple strategies for the commercialization of our technologies, but we are placing increasing emphasis on the creation of products and product awareness.

      We are also decreasing our emphasis on further research and development.

      For the quarter ended September 30, 2009 as shown below, sales and marketing expenses are up $224,876, or 65%, from the same period in 2008.

      A significant portion of this increase is related to the creation of a new national sales representation organization.

      Buy on a dip: (.0435)

      • 1 Reply to CJL72
      • Revenue Range:6 - 10M.....!!!

        Apparently we have not left Exit 17;But the synergy applies locally as well for the next 8 weeks.....I have been removed;and that is probably the correct move for the time specified.hahahaha!!!!!Never a big fan of energy drinks or AB products;hahaha!!!

        CF,NTA,Rev:Unadjusted:,1.0799M,0.07/Share

        CF,NTA, RevAdjusted: $$M 4.17, 0.27 Per Share.
        Recent High Price: 0.082
        Price Target Less Than: [1.] 0.081_6016, (0.000398), (0.49%)
        Price to Scheduled Amounts: [2.] 0.307_178

        Revenue Annualized: 6.60_11M, [8.] 6.6011M, 0.420878/Share, 0.193_884PriceTo
        Brooklyn & Media PA, Business Intelligence Issues: [9.] 3.09 $$M, 0.196_799/Share
        [10.] 0.415PriceTo

        [11.]: 11 Adjusted Book$$M: 1.902_972M, 0.1213/Share, 0.672_548
        [12.] 6 Mos Return: Minus: 0.1203, 0.08, (32.15%)
        [13.] Add. Paid in Capital to Equity:20.08M:w/ Equity @.965M: Common Stock: 50M Shares Authorized: 0.040092M, 0.0026, 31.92PriceTo

        Weighted Average Price, Price Metric:
        0.13_67, 0.57

        Trading @ : (0.0547), (0.261_0827)


        I will comment, that this is a clean Consumer Driven R&D Tech company.....and should not be considered as anything negative.....

        Our principal area of focus is exercise performance and recovery, including optimal weight management. Our products can be marketed without prior Food and Drug Administration (“FDA”) approval under current regulatory guidelines.

        Evolving into a more consumer oriented, brand driven company that derives value from its own brands based on our science-based R&D Nutrition technology.

        1 CNY = 0.097_3_896 GBP

        Overview:
        http://finance.yahoo.com/q/pr?s=PHLI.OB+Profile

        Share Price:'07:$3.77;

        I will keep my distance.....hahaha!!!

        THANKS!!!!!

    • What difference does it make....this is a TOTAL looser!!!!!!

    • I will take a guess, but only a guess. Q3 Conference Call was Oct 28. If the pattern holds true that should put the Q4 CC on or about Jan 28.

      Looking for Q4 Rev of $1.1mil+ which would be nice, but still expect a negative net profit for q4. Any q4 net loss of less than $100k would be very good news. I'll take a guess at the actual q4 loss being about $370,000 and annual loss being around $930,000. Guesses.

      Long here obviously.

 
PHLI
0.0260.000(0.00%)May 27 10:34 AMEDT